| Serial Number | 97810745 |
| Word Mark | TRIVENI |
| Filing Date | Friday, February 24, 2023 |
| Status | 645 - FINAL REFUSAL - MAILED |
| Status Date | Tuesday, June 4, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | NOT AVAILABLE |
| Goods and Services | Pharmaceutical, therapeutic and biopharmaceutical agents for treatment of immunological and inflammatory disorders; pharmaceutical, therapeutic and biopharmaceutical preparations and substances; biological preparations, namely, antibodies |
| Goods and Services | Research and development of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; research and development of technology in the field of pharmaceutical, therapeutic and biopharmaceutical preparations and agents; pharmaceutical drug development and discovery; research and analysis services using machine learning analytics relating to drug development; scientific research, pharmaceutical research, medical research, technical consultation, and product development for others in the field of biotechnology and development of pharmaceutical, therapeutic, and biopharmaceutical preparations and agents; research services in the fields of genomic analysis; scientific research, namely, genomic analysis and sequencing services for scientific and research purposes; medical and scientific research in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; scientific research, namely, DNA analysis and sequencing services for scientific and research purposes; scientific research, development and scientific research consultancy in the field of genomics; medical research, namely, compiling data for research purposes in the field of genomics; providing on-line non-downloadable software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, meta-transcriptomics, and microbiomics; platform as a service (PaaS) featuring computer software platforms for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, metatranscriptomics, and microbiomics; software as a service (SaaS) services featuring software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, epigenomics, metabolomics, meta-genomics, metatranscriptomics |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, March 15, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Wednesday, May 29, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | TRIVENI BIO, INC. |
| Party Type | 11 - New Owner Before Publication |
| Legal Entity Type | 03 - Corporation |
| Address | WALTHAM, MA 02453 |
| Party Name | Amagma, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Waltham, MA 02453 |
| Event Date | Event Description |
| Wednesday, March 15, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Saturday, November 25, 2023 | ASSIGNED TO EXAMINER |
| Thursday, November 30, 2023 | NON-FINAL ACTION WRITTEN |
| Thursday, November 30, 2023 | NON-FINAL ACTION E-MAILED |
| Thursday, November 30, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, January 5, 2024 | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED |
| Wednesday, May 29, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Wednesday, May 29, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, January 5, 2024 | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED |
| Wednesday, January 17, 2024 | AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP |
| Wednesday, May 29, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, June 4, 2024 | FINAL REFUSAL E-MAILED |
| Tuesday, June 4, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Tuesday, June 4, 2024 | FINAL REFUSAL WRITTEN |